"Living With Fibromyalgia" is the first feature-length film about fibromyalgia, providing an honest, personal, and practical look at how to live with this chronic pain condition through profiles of seven patients and interviews with fibromyalgia experts. It's told by the daughter of a fibromyalgia patient. It has been called a "milestone" for the fibromyalgia community and a "must-see" for fibromyalgia patients and those who love them by the President of the National Fibromyalgia Association, Lynne Matallana.
Learn more at: http://www.LivingWithFM.com
Video Tags:living, with, fibromyalgia, documentary, film, trailer, stephen, eyer, daneen, akers
Related Videos:





Fibromyalgia Support Group will meet on Monday (Lake Elmo Leader)
The Fibromyalgia Support Group will meet on Monday, Feb. 23, from 7-8:30 p.m. at Courage St. Croix, 1460 Curve Crest Blvd. in Stillwater. Advertisement: TATRO FITNESS Free Fitness Assessment and Session Sign up for 10 or more sessions by 3/31 and get a FREE FITNESS ASSESSMENT and get your FIRST EXERCISE SESSION FREE!! Tatro Fitness, 763-528-1632
Fibromyalgia Support Group will meet on Monday (Stillwater Courier)
The Fibromyalgia Support Group will meet on Monday, Feb. 23, from 7-8:30 p.m. at Courage St. Croix, 1460 Curve Crest Blvd. in Stillwater. Advertisement: FEUERHELM LANGER LTD Receive your individual TAX REFUND in LESS THAN 14 DAYS Get started now, call 651-646-6446. Feuerhelm Langer, Ltd
Pfizer drops development of 2 drugs (BizJournals)
Pfizer Inc. said Tuesday it is terminating two development programs, one for a drug to treat fibromyalgia, a condition of chronic widespread pain, and another for a drug to treat generalized anxiety disorder.
Pfizer kills fibromyalgia, anxiety drugs - Asbury Park Press Pfizer Inc. said it halted late-stage human tests on drugs for fibromyalgia and anxiety to invest its money on more promising treatments. The drugs, esreboxetine for fibromyalgia and PD-332334 for generalized anxiety disorder, were in the last of three ...
UCB's Phase IIa fibromyalgia and migraine trials fail primary endpoint - Pharmaceutical Business Review ... company UCB has announced top-line results from two proof-of-concept Phase IIa clinical trials to assess the efficacy and safety of lacosamide in migraine prophylaxis, and the efficacy and safety of rotigotine in fibromyalgia syndrome. ...
Judge allows Delphi to end benefits - Los Angeles Times The world's biggest drug maker said it decided to halt more testing of compounds to treat fibromyalgia and generalized anxiety disorder after reviewing its existing and experimental primary-care drugs. Neither compound had been seen as a likely ...
Flickr pictures related to fibromyalgia









No comments:
Post a Comment